Biochemical and immunological evaluation of donor-specific soluble HLA in the circulation of liver transplant recipients

Transplantation

Volumn 62, Issue 2, 1996, Pages 217-223

  Mathew, James M ^a,b   Shenoy, Surendra ^a   Phelan, Donna ^a   Lowell, Jeffrey ^a   Howard, Todd ^a   Mohanakumar, T ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; HLA A3 ANTIGEN; HLA ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN; PREDNISOLONE;

ADULT; ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; DIAGNOSTIC APPROACH ROUTE; FEMALE; GRAFT REJECTION; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; LIVER TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADULT; ANTIGEN-ANTIBODY COMPLEX; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITOPES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULINS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; SODIUM DODECYL SULFATE; SOLUBILITY; T-LYMPHOCYTES, CYTOTOXIC; TISSUE DONORS;

EID: 0030003245     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199607270-00012     Document Type: Article

References (37)

1. Koller BH, Marrack P, Kappler JW, Smithies O. Normal development of mice deficient in beta-2 microglobulin, MHC class I proteins, and CD8+ T cells. Science 1990; 248: 1227.
2. Zingernagel RM, Doherty PC. MHC restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T cell restriction specificity, function and responsiveness. Adv Immunol 1979; 27: 51.
3. Bach FH, Sacks DH. Current concepts: immunology - transplantation immunology. N Engl J Med 1987; 317: 489.
4. Ramanathan L, Rogers MJ, Robinson EA, Hearing VJ, Tanigaki N, Apella E. Biochemical analysis of a 40,000 molecular weight mouse serum protein which binds beta2-microglobulin and has serological cross-reactivity with H-2 antigens. Mol Immunol 1982; 19: 1075.
5. Spencer S, Fabre JW. Identification in rat liver and serum of water soluble class I MHC molecules possibly homologous to the murine Q10 gene product. J Exp Med 1987; 165: 1595.
6. Van Rood JJ, Van Leeuven A, Van Santen MCT. Anti-HA-A2 inhibition in normal human serum. Nature 1970; 226: 366.
7. Dobbe ME, Stam NJ, Neefjes J, Giphart MJ. Biochemical complexity of serum HLA class I molecules. Immunogenetics 1988; 27: 203.
8. Villar LM, Roy G, Lazaro I, et al. Detection of soluble class I molecules (non HLA-A or HLA-B) in serum, spleen membranes and lymphocytes in culture. Eur J Immunol 1989; 19: 1835.
9. Alvarez-Cermeno JC, Casado C, Villar LM, et al. Soluble class I andtigens (sHLA) in CSF and serum of patients with HIV infection. Acta Neurol Scand 1990; 82: 14.
10. Alvarez-Cermeno JC, Echevarria JM, Villar LM, Lazaro I, Bootello A, Gonzalez-Porque P. Soluble class I antigens in serum and CSF of patients with varicella-zoster virus meningitis. J Neurol Neurosurg Psychiatry 1989; 52: 1194.
11. Ferreira A, Villar LM, Alverez-Cermeno J, et al. Quantification of soluble serum HLA class I antigens in healthy volunteers and AIDS patients. Clin Chim Acta 1988; 174: 207.
12. Davies HS, Pollard SG, Calne RY. Soluble HLA antigens in the circulation of liver graft recipients. Transplantation 1989; 47: 524.
13. Rhynes KV, McDonald JC, Gelder FB, et al. Soluble HLA class I in the serum of transplant recipients. Ann Surg 1993; 217: 485.
14. Tug H, Westhoff U, Vogel W, et al. Soluble HLA class I serum concentrations increase with transplant related complications after liver transplantation. J Hepatol 1992; 62: 29.
15. Chauhan B, Mathew JM, Shenoy S, Flye WM, Howard T, Mohanakumar T. Donor human leukocyte antigens in the circulation of liver allograft recipients. Clin Transplant 1995; 9: 14.
16. Allison JP, Pellegrino MA, Ferrone S, Callahan GN, Reisfeld RA. Biologic and chemical characterization of HLA antigens in human serum. J Immunol 1977; 118: 1004.
17. Dobbe LME, Stam NJ, Neefjes JJ, Giphart MJ. Biochemical complexity of serum HLA class I molecules. Immunogenetics 1988; 27: 203.
18. Haga JA, She JX, Kao JK. Bicochemical characterization of 39-kDa class I histocompatability antigen in plasma. J Biol Chem 1991; 266: 3695.
19. Krangel MS. Unusual RNA splicing generates a secreted form of HLA-A2 in a mutagenized B lymphoblastoid cell line. EMBO J 1985; 4: 1205.
20. Krangel MS. Secretion of HLA-A and -B antigens via an alternate RNA splicing pathway. J Exp Med 1986; 163: 1173.
21. Krangel MS. Two forms of HLA class I molecules in human plasma. Hum Immunol 1987; 20: 155.
22. Clayberger C, Parham P, Rothbard J, Ludwig DS, Schoolnik GK, Krensky AM. HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes. Nature 1987; 330: 764.
23. Schneck J, Munitz T, Coligan JE, Maloy WL, Margulies DH, Singer A. Inhibition of allorecognition by an H-2K-b derived peptide is evidence for a T-cell binding region on a major histocompatibility complex molecule. Proc Natl Acad Sci USA 1989; 86: 8516.
24. Schneck J, Maloy WL, Coligan JE, Margulies DH. Inhibition of an allospecific T cell hybridoma by soluble class I proteins and peptides: estimation of affinity of a T cell receptor for MHC. Cell 1989; 56: 47.
25. Zavazava N, Hausmann R, Muller-Ruchholtz W. Inhibition of anti-HLA-B7 alloreactive CTL by affinity-purified soluble HLA. Transplantion 1991; 51: 838.
26. Hausmann R, Zavazava N, Steinmann J, Muller-Ruchholtz W. Interaction of papain-digested HLA class I molecules with human alloreative cytotoxic T lymphocytes (CTL). Clin Exp Immunol 1993; 91: 183.
27. Foster S, Wood KJ, Morris PJ. The effectiveness of pretreatment with soluble or membrane-bound donor class I major histocompatibility complex antigens in the induction of unresponsiveness to a subsequent rat renal allograft. Transplantation 1992; 53: 1322.
28. Nabozny GH, Krco CJ, Pawelski JR, David CS. Specific induction of hyporesponsiveness to alloantigens in adult mice using synthetic peptides of major histocompatibility complex (MHC) molecules. Big Sky, '93: Third Basic Science Symposium of the Transplantation Society 1993. III: 67.
29. Cuturi MC, Josien R, Cantarovich D, et al. Prolongation of heart allograft survival time in adult rats by intravenous injection of a synthetic HLA peptide derived from the alpha-1 domain of HLA class I heavy chain. Big Sky, '93: Third Basic Science Symposium of The Transplantation Society 1993. III: P87.
30. Nisco S, Vriens P, Hoyt G, Pouletty P, Reitz B, Clayberger C. Synthetic peptides corresponding to conserved regions of HLA class I molecules are immunosuppressive in vivo. Big Sky, '93: Third Basic Science Symposium of The Transplantation Society 1993. III: S17.
31. Rodey GE, Sturn B, Aster RH. Cross-reactive HLA antibodies: separation from multiple HLA antibody specificities by platelet absorption and acid elution. Tissue Antigens 1973; 3: 63.
32. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W. Current protocols in immunology. In: Current protocols in immunology, Vol 1. New York: Wiley-Interscience, 1993: 301.
33. Parham P. Purification of immunologically active HLA-A and -B antigens by a series of monoclonal antibody columns. J Biol Chem 1979; 254: 8709.
34. Laemmli UK. Cleavage of structural proteins during assembly of bacteriophage T-4. Nature 1970; 227: 680.
35. Mathew J, Joyce S, Lawrence W, Mohanakumar T. Evidence that antibodies eluted from rejected kidneys of HLA-identical transplants define a non-MHC alloantigen expressed on human kidneys. Transplantation 1991; 52: 559.
36. Mathew JM, Marsh JW, Susskind BM, Mohanakumar T. Analysis of T cell responses in liver allograft recipients: evidence for deletion of donor specific cytotoxic T cells in the peripheral circulation. J Clin Invest 1993; 91: 900.
37. Changelian PS, Jack RM, Collins LA, Fearon DT. PMA induces the igand-independent internalization of CR1 on human neutrophils. J Immunol 1985; 134: 1851.